In This Issue:

- Confusion Persists in Anticipation of 340B “Mega-Rule”

- Implementation of the Affordable Care Act

- Other Federal Regulatory Initiatives

- Other Congressional and State Initiatives

- Other Health Care News

- Upcoming Hearings and Markups

- Excerpt from Confusion Persists in Anticipation of 340B “Mega-Rule”:

The 340B drug discount program continues to be one of the most scrutinized and anticipated areas of health policy regulation going into the summer. The 340B program provides discounts between 20 and 50 percent off the cost of pharmaceuticals to providers, such as hospitals and community health centers. While the program was initially created to provide affordable access to providers serving overwhelmingly needy communities, the ACA’s expansion of eligible providers to critical access hospitals (CAHs) and children’s hospitals, among others, has drawn the intense scrutiny of lawmakers and drug manufacturers alike.

Please see full update below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Topics:  340B, Affordable Care Act, Critical Access Hospitals, Healthcare, Healthcare Reform, Hospitals, Pharmaceutical, Prescription Drugs

Published In: Administrative Agency Updates, Elections & Politics Updates, Health Updates, Science, Computers & Technology Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Mintz Levin - Health Law & Policy Matters | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »